Skip to main content

Part of Cancer staging guidance sheets

Colon and rectum (ICD10 C18-C20)

Current Chapter

Current chapter – Colon and rectum (ICD10 C18-C20)


Introduction

This is the data sheet for TNM 8th edition staging of the colon and rectum (ICD10 C18-C20)

For more detailed information regarding TNM staging, please see pages 73-76 of the UICC TNM 8 book or visit the Wiley and UICC website.


Stage groupings

Stage Group

T stage

N stage

M stage

Stage 0

Tis

N0

M0

Stage I

T1, T2

N0

M0

Stage II

T3, T4

N0

M0

Stage IIA

T3

N0

M0

Stage IIB

T4a

N0

M0

Stage IIC

T4b

N0

M0

Stage III

Any T

N1, N2

M0

Stage IIIA

T1, T2

N1

M0

 

T1

N2a

M0

Stage IIIB

T1, T2

N2b

M0

T2, T3

N2a

M0

T3, T4a

N1

M0

Stage IIIC

T3, T4a

N2b

M0

T4a

N2a

M0

T4b

N1, N2

M0

Stage IV

Any T

Any N

M1

Stage IVA

Any T

Any N

M1a

Stage IVB

Any T

Any N

M1b

Stage IVC

Any T

Any N

M1c


TNM clinical classification

T - primary tumour

T value Description

TX

Primary tumour cannot be assessed

T0

No evidence of primary tumour

Tis

Carcinoma in situ: invasion of lamina propria

T1

Tumour invades submucosa

T2

Tumour invades muscularis propria

T3

Tumour invades subserosa or into non‐peritonealized pericolic or perirectal tissues

T4

Tumour directly invades other organs or structures and/or perforates visceral peritoneum T4a - Tumour perforates visceral peritoneum

T4b - Tumour directly invades other organs or structures

T4b - Tumour directly invades other organs or structures

N - regional lymph nodes

N value Description

NX

Regional lymph nodes cannot be assessed

N0

No regional lymph node metastasis

N1

Metastasis in 1 to 3 regional lymph nodes

N1a - Metastasis in 1 regional lymph node

N1b - Metastasis in 2 to 3 regional lymph nodes

N1c - Tumour deposit(s), i.e. satellites,* in the subserosa, or in non‐peritonealized pericolic or perirectal soft tissue without regional lymph node metastasis

N2

Metastasis in 4 or more regional lymph nodes

N2a - Metastasis in 4–6 regional lymph nodes

N2b - Metastasis in 7 or more regional lymph nodes

Notes:

* Tumour deposits (satellites) are discrete macroscopic or microscopic nodules of cancer in the pericolorectal adipose tissue’s lymph drainage area of a primary carcinoma that are discontinuous from the primary and without histological evidence of residual lymph node or identifiable vascular or neural structures. If a vessel wall is identifiable on H&E, elastic or other stains, it should be classified as venous invasion (V1/2) or lymphatic invasion (L1). Similarly, if neural structures are identifiable, the lesion should be classified as perineural invasion (Pn1). The presence of tumour deposits does not change the primary tumour T category, but changes the node status (N) to pN1c if all regional lymph nodes are negative on pathological examination.

M - distant metastasis

M value Description

M0

No distant metastasis

M1

Distant metastasis

M1a - Metastasis confined to one organ (liver, lung, ovary, non‐regional lymph node(s)) without peritoneal metastases

M1b - Metastasis in more than one organ

M1c - Metastasis to the peritoneum with or without other organ involvement


TNM pathological classification

pT - primary tumour

The pT categories correspond to the T categories as per above.

pN - regional lymph nodes

Histological examination of a selective neck dissection specimen will ordinarily include 10 or more lymph nodes. Histological examination of a radical or modified radical neck dissection specimen will ordinarily include 15 or more lymph nodes.

pN value Description

pN0

Histological examination of a regional lymphadenectomy specimen will ordinarily include 12 or more lymph nodes. If the lymph nodes are negative, but the number ordinarily examined is not met, classify as pN0


Download

Click on the box below to download a PDF version of this data sheet:

Last edited: 14 December 2022 12:24 pm

  1. Cancer staging guidance sheets
  2. Lip and oral cavity (ICD10 C00, C02-C06)
  3. Malignant melanoma of upper aerodigestive tract (ICD10 C00-06, C10-14, C30-32)
  4. Pharynx (ICD10 C01, C05.1-2, C09, C10.0, C10.2-3, C11-13)
  5. Major salivary glands (ICD10 C07, C08)
  6. Oesophagus including oesophagastric junction (ICD10 C15 & C16.0)
  7. Stomach (ICD10 C16 except C16.0)
  8. Small intestine (ICD10 C17)
  9. Appendix (ICD10 C18.1)
  10. Colon and rectum (ICD10 C18-C20)
  11. Anal canal and perianal skin data (ICD10 C21, C44.5)
  12. Liver (ICD10 C22.0)
  13. Intrahepatic bile ducts (ICD10 C22.1)
  14. Gallbladder (ICD10 C23, C24.0)
  15. Distal extrahepatic bile duct (ICD10 C24.0)
  16. Perihilar bile ducts (ICD10 C24.0)
  17. Ampulla of vater (ICD10 C24.1)
  18. Pancreas (ICD10 C25)
  19. Nasal cavity and paranasal sinuses (ICD10 C30.0, C31.0, C31.1)
  20. Larynx (ICD10 C32.0 C32.1, C32.2, C10.1)
  21. Lung (ICD10 C34)
  22. Thymic tumours (ICD10 C37)
  23. Soft tissues (ICD10 C38.1-2, C47-C49)
  24. Bone (ICD10 C40 & C41)
  25. Malignant melanoma of skin (ICD10 C43, C51.0, C60.9, C63.2)
  26. Merkel cell carcinoma of skin (ICD10 C44 & C63.2)
  27. Skin carcinoma of the head and neck (ICD10 C44.0, C44.2-4)
  28. Carcinoma of skin of the eyelid (ICD10 C44.1)
  29. Carcinoma of skin (excluding eyelid, head and neck, perianal, vulva and penis) (ICD10 C44.5-7, C63.2)
  30. Pleural mesothelioma (ICD10 C45)
  31. Breast tumours (ICD10 C50)
  32. Vulva (ICD10 C51)
  33. Cervix uteri (ICD10 C53)
  34. Uterine sarcomas
  35. Uterus - endometrium (ICD10 C54.1, C55)
  36. Ovarian, fallopian tube and primary peritoneal carcinoma (ICD10 C56, C57, C48.1, C48.2)
  37. Gestational trophoblastic neoplasms (ICD10 C58)
  38. Penis tumours (ICD10 C60)
  39. Prostate tumours (ICD10 C61)
  40. Testis tumours (ICD10 C62)
  41. Kidney tumours (ICD10 C64)
  42. Renal pelvis and ureter tumours (ICD10 C65 & C66)
  43. Urinary bladder tumours (ICD10 C67)
  44. Urethra tumours (ICD10 C68.0)
  45. Carcinoma of conjuctiva (ICD10 C69.0)
  46. Malignant melanoma of conjuctiva (ICD10 C69.0)
  47. Retinoblastoma (ICD10 C69.2)
  48. Malignant melanoma of uvea (ICD10 C69.3, C69.4)
  49. Carcinoma of lacrimal gland (ICD10 C69.5)
  50. Sarcoma of orbit (ICD10 C69.6)
  51. Thyroid gland (ICD10 C73)
  52. Adrenal cortex (ICD10 C74.0)
  53. Chronic lymphocytic leukaemia
  54. Hepatoblastoma (CTYA)
  55. Hodgkins and non-hodgkins lymphoma (ICD10 C81-88)
  56. Medulloblastoma
  57. Multiple myeloma
  58. Neuroblastoma
  59. Neuroendocrine tumours of the foregut
  60. Neuroendocrine tumours of the midgut and hindgut
  61. Non-hodgkin lymphoma (children)
  62. Rhabdomyosarcoma and other soft tissue sarcomas (CTYA)
  63. Wilms tumour of the kidney